IL257400A - Purification of fkpa and its uses for the production of recombinant polypeptides - Google Patents
Purification of fkpa and its uses for the production of recombinant polypeptidesInfo
- Publication number
- IL257400A IL257400A IL257400A IL25740018A IL257400A IL 257400 A IL257400 A IL 257400A IL 257400 A IL257400 A IL 257400A IL 25740018 A IL25740018 A IL 25740018A IL 257400 A IL257400 A IL 257400A
- Authority
- IL
- Israel
- Prior art keywords
- fkpa
- purification
- recombinant polypeptides
- producing recombinant
- producing
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 238000000746 purification Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/165—Extraction; Separation; Purification by chromatography mixed-mode chromatography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/563—Immunoassay; Biospecific binding assay; Materials therefor involving antibody fragments
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y502/00—Cis-trans-isomerases (5.2)
- C12Y502/01—Cis-trans-Isomerases (5.2.1)
- C12Y502/01008—Peptidylprolyl isomerase (5.2.1.8), i.e. cyclophilin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/99—Isomerases (5.)
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562207910P | 2015-08-20 | 2015-08-20 | |
| US201562207908P | 2015-08-20 | 2015-08-20 | |
| US201562210378P | 2015-08-26 | 2015-08-26 | |
| PCT/US2016/047912 WO2017031476A2 (en) | 2015-08-20 | 2016-08-19 | Purification of fkpa and uses thereof for producing recombinant polypeptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL257400A true IL257400A (en) | 2018-04-30 |
Family
ID=58052052
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL257400A IL257400A (en) | 2015-08-20 | 2018-02-07 | Purification of fkpa and its uses for the production of recombinant polypeptides |
| IL288205A IL288205A (en) | 2015-08-20 | 2021-11-17 | Purification of fkpa and its uses for the production of recombinant polypeptides |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL288205A IL288205A (en) | 2015-08-20 | 2021-11-17 | Purification of fkpa and its uses for the production of recombinant polypeptides |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20180327446A1 (enExample) |
| EP (1) | EP3337819B1 (enExample) |
| JP (2) | JP7091238B2 (enExample) |
| KR (1) | KR20180048731A (enExample) |
| CN (1) | CN108473558A (enExample) |
| AU (1) | AU2016308383A1 (enExample) |
| BR (1) | BR112018003127A2 (enExample) |
| CA (1) | CA2995385A1 (enExample) |
| HK (1) | HK1259368A1 (enExample) |
| IL (2) | IL257400A (enExample) |
| MX (1) | MX2018002068A (enExample) |
| TW (1) | TW201718623A (enExample) |
| WO (1) | WO2017031476A2 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9458450B2 (en) | 2012-03-15 | 2016-10-04 | Flodesign Sonics, Inc. | Acoustophoretic separation technology using multi-dimensional standing waves |
| US10704021B2 (en) | 2012-03-15 | 2020-07-07 | Flodesign Sonics, Inc. | Acoustic perfusion devices |
| CA2935960C (en) | 2014-01-08 | 2023-01-10 | Bart Lipkens | Acoustophoresis device with dual acoustophoretic chamber |
| US11708572B2 (en) | 2015-04-29 | 2023-07-25 | Flodesign Sonics, Inc. | Acoustic cell separation techniques and processes |
| US11377651B2 (en) | 2016-10-19 | 2022-07-05 | Flodesign Sonics, Inc. | Cell therapy processes utilizing acoustophoresis |
| US11459540B2 (en) | 2015-07-28 | 2022-10-04 | Flodesign Sonics, Inc. | Expanded bed affinity selection |
| US11474085B2 (en) | 2015-07-28 | 2022-10-18 | Flodesign Sonics, Inc. | Expanded bed affinity selection |
| US11085035B2 (en) | 2016-05-03 | 2021-08-10 | Flodesign Sonics, Inc. | Therapeutic cell washing, concentration, and separation utilizing acoustophoresis |
| US11214789B2 (en) | 2016-05-03 | 2022-01-04 | Flodesign Sonics, Inc. | Concentration and washing of particles with acoustics |
| KR20220066413A (ko) | 2017-12-14 | 2022-05-24 | 프로디자인 소닉스, 인크. | 음향 트랜스듀서 구동기 및 제어기 |
| CN111801120A (zh) * | 2017-12-29 | 2020-10-20 | 豪夫迈·罗氏有限公司 | 用于提供聚乙二醇化蛋白质组合物的方法 |
| CN111741770A (zh) | 2017-12-29 | 2020-10-02 | 豪夫迈·罗氏有限公司 | 用于提供聚乙二醇化蛋白质组合物的方法 |
| KR20240067985A (ko) * | 2018-02-27 | 2024-05-17 | 화이자 인코포레이티드 | 항체 정제 |
| MX2020009788A (es) * | 2018-03-21 | 2020-12-09 | Takeda Pharmaceuticals Co | Separación de factor de von willebrand (vwf) y propéptido de factor de von willebrand (vwf) por métodos cromatográficos. |
| US11453883B2 (en) | 2018-04-05 | 2022-09-27 | Bio-Rad Abd Serotec Gmbh | Display systems for proteins of interest |
| EP3856347A1 (en) * | 2018-09-25 | 2021-08-04 | Ichnos Sciences SA | Antibody quantification in biological samples |
| CN114409798A (zh) * | 2019-02-14 | 2022-04-29 | 美勒斯公司 | 制备包含两种或更多种抗体的组合物 |
| EP3942079A1 (en) * | 2019-03-18 | 2022-01-26 | Bio-Rad ABD Serotec GmbH | Protection of spytag-containing periplasmic fusion proteins from protease tsp and ompt degradation |
| EP3962924A1 (en) | 2019-05-03 | 2022-03-09 | Genentech, Inc. | Methods of reducing the enzymatic hydrolysis activity rate in a composition obtained from a purification platform |
| CN114829589A (zh) * | 2019-12-20 | 2022-07-29 | 默沙东有限公司 | 纯化的肠道病毒的组合物和使用谷胱甘肽亲和色谱的纯化方法 |
| AU2021224852A1 (en) * | 2020-02-21 | 2022-10-13 | Biogen Ma Inc. | Methods of preparing oligonucleotide compositions using ultrafiltration / diafiltration |
| EP4118093A4 (en) * | 2020-03-11 | 2024-04-17 | Dr. Reddy's Laboratories Ltd. | METHOD FOR PURIFYING A FC FUSION PROTEIN |
| CA3233419A1 (en) * | 2021-09-28 | 2023-04-06 | Kashiv Biosciences, Llc | An improved process for purification of protein |
| EP4437344A1 (en) * | 2021-11-25 | 2024-10-02 | F. Hoffmann-La Roche AG | Quantification of low amounts of antibody sideproducts |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60135498D1 (de) * | 2000-12-14 | 2008-10-02 | Genentech Inc | Produktion von ganzen Antikörpern in prokaryontischen Zellen |
| KR20170023209A (ko) * | 2008-05-05 | 2017-03-02 | 노비뮨 에스 에이 | 항-ｉｌ-１７ａ／ｉｌ-１７ｆ 교차-반응성 항체 및 그의 사용 방법 |
| KR20110091678A (ko) | 2008-10-20 | 2011-08-12 | 아보트 러보러터리즈 | 단백질 ａ 친화성 크로마토그래피를 이용한 항체의 분리 및 정제 |
| PL3037104T3 (pl) | 2009-10-20 | 2020-11-16 | Abbvie Inc. | Izolacja i oczyszczanie przeciwciał anty-il-13 z zastosowaniem chromatografii powinowactwa z białkiem a |
| WO2013028330A2 (en) | 2011-08-19 | 2013-02-28 | Emd Millipore Corporation | Methods of reducing level of one of more impurities in a sample during protein purification |
| JP6092892B2 (ja) | 2011-12-15 | 2017-03-08 | プレステージ バイオファーマ プライベート リミテッド | 抗体の精製方法 |
| WO2013102042A2 (en) * | 2011-12-30 | 2013-07-04 | Abbvie Inc. | Dual specific binding proteins directed against il-13 and/or il-17 |
| CN119979504A (zh) | 2013-01-09 | 2025-05-13 | 武田药品工业株式会社 | 含用于纯化芳基硫酸酯酶a的方法 |
| BR112015024553A2 (pt) * | 2013-04-05 | 2017-10-24 | Genentech Inc | anticorpo multiespecífico, anticorpo isolado, ácido nucleico isolado, célula hospedeira, método de produção de anticorpo, imunoconjugado, formulação farmacêutica, uso de anticorpo e método de tratamento de indivíduos com distúrbio |
| CA2909516C (en) * | 2013-04-19 | 2023-03-07 | Sutro Biopharma, Inc. | Expression of biologically active proteins in a bacterial cell-free synthesis system using cell extracts with elevated levels of exogenous chaperones |
| CN118271429A (zh) * | 2013-08-19 | 2024-07-02 | 豪夫迈·罗氏有限公司 | 用羟基磷灰石层析分离双特异性抗体和双特异性抗体生产副产物 |
| CN105722532A (zh) * | 2013-09-13 | 2016-06-29 | 豪夫迈·罗氏有限公司 | 包含纯化的重组多肽的方法和组合物 |
| EP3066123A1 (en) | 2013-11-07 | 2016-09-14 | AbbVie Inc. | Isolation and purification of antibodies |
| JP2017507939A (ja) * | 2014-02-21 | 2017-03-23 | ジェネンテック， インコーポレイテッド | 抗ｉｌ−１３／ｉｌ−１７二重特異性抗体及びその使用 |
-
2016
- 2016-08-19 KR KR1020187007920A patent/KR20180048731A/ko not_active Ceased
- 2016-08-19 WO PCT/US2016/047912 patent/WO2017031476A2/en not_active Ceased
- 2016-08-19 BR BR112018003127A patent/BR112018003127A2/pt not_active IP Right Cessation
- 2016-08-19 HK HK19101736.6A patent/HK1259368A1/zh unknown
- 2016-08-19 TW TW105126681A patent/TW201718623A/zh unknown
- 2016-08-19 CN CN201680061356.3A patent/CN108473558A/zh active Pending
- 2016-08-19 MX MX2018002068A patent/MX2018002068A/es unknown
- 2016-08-19 EP EP16758343.4A patent/EP3337819B1/en active Active
- 2016-08-19 CA CA2995385A patent/CA2995385A1/en not_active Abandoned
- 2016-08-19 JP JP2018509536A patent/JP7091238B2/ja active Active
- 2016-08-19 AU AU2016308383A patent/AU2016308383A1/en not_active Abandoned
-
2018
- 2018-02-07 IL IL257400A patent/IL257400A/en unknown
- 2018-02-16 US US15/932,222 patent/US20180327446A1/en not_active Abandoned
-
2021
- 2021-11-17 IL IL288205A patent/IL288205A/en unknown
-
2022
- 2022-01-13 JP JP2022003518A patent/JP2022062046A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3337819A2 (en) | 2018-06-27 |
| BR112018003127A2 (pt) | 2018-09-25 |
| JP2018533355A (ja) | 2018-11-15 |
| TW201718623A (zh) | 2017-06-01 |
| MX2018002068A (es) | 2018-06-06 |
| CA2995385A1 (en) | 2017-02-23 |
| EP3337819B1 (en) | 2024-02-21 |
| AU2016308383A1 (en) | 2018-03-15 |
| JP2022062046A (ja) | 2022-04-19 |
| IL288205A (en) | 2022-01-01 |
| HK1259368A1 (zh) | 2019-11-29 |
| KR20180048731A (ko) | 2018-05-10 |
| WO2017031476A3 (en) | 2017-04-13 |
| US20180327446A1 (en) | 2018-11-15 |
| JP7091238B2 (ja) | 2022-06-27 |
| CN108473558A (zh) | 2018-08-31 |
| WO2017031476A2 (en) | 2017-02-23 |
| EP3337819C0 (en) | 2024-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL288205A (en) | Purification of fkpa and its uses for the production of recombinant polypeptides | |
| GB201706477D0 (en) | Modification of polypeptides | |
| EP3236772A4 (en) | Methods of purifying recombinant proteins | |
| IL250007A0 (en) | Fusion protein of interleukin-2 and receptor for interleukin-2 alpha and methods of use | |
| IL284236A (en) | Modifications and uses of conotoxin peptides | |
| SI3197472T1 (sl) | Rekombinantni proteini brez PHE za uporabo pri zdravljenju fenilketonurije | |
| GB201518792D0 (en) | Production of proteins | |
| ZA201700483B (en) | Interferon alpha and omega antibody antagonists | |
| HUP1500363A2 (en) | Method for increasing the galactose content of recombinant proteins | |
| IL251799A0 (en) | Serpin-fused polypeptides and methods of using them | |
| IL254765A0 (en) | A method for the monomerization of recombinant antibody molecules | |
| EP3377633C0 (en) | PRODUCTION OF RECOMBINANT PROTEINS | |
| IL295361A (en) | Efficient selectivity of recombinant proteins | |
| PL3250535T3 (pl) | Sposób wytwarzania cementu o wysokiej zawartości tlenku glinu | |
| IL255819A (en) | An improved process for the preparation of sofosbuvir and intermediates | |
| EP3268042C0 (en) | COMPOSITION CONTAINING AN ANTI-TNF-ALPHA POLYPEPTIDE AND USE | |
| PL3224222T3 (pl) | Kompozycja kompozytu ceramicznego i sposób jej formowania | |
| IL253077A0 (en) | Process and intermediates for the preparation of Fermpanel | |
| IL256706B (en) | A method for making recombinant proteins | |
| IL256707B (en) | A method for the production of recombinant proteins | |
| GB201622143D0 (en) | Modification of polypeptides | |
| GB201713559D0 (en) | Modification of polypeptides | |
| GB201509143D0 (en) | Methods of characterizing polypeptides | |
| GB201504211D0 (en) | Use of peptides |